PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Up 50.8% in October

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large growth in short interest in October. As of October 31st, there was short interest totalling 46,600 shares, a growth of 50.8% from the October 15th total of 30,900 shares. Based on an average trading volume of 50,300 shares, the short-interest ratio is currently 0.9 days.

PURE Bioscience Price Performance

Shares of PURE stock remained flat at $0.16 on Friday. 21,473 shares of the company were exchanged, compared to its average volume of 28,810. The stock has a market cap of $17.62 million, a P/E ratio of -3.94 and a beta of 0.05. The company’s fifty day moving average price is $0.09 and its 200 day moving average price is $0.08. PURE Bioscience has a 12-month low of $0.06 and a 12-month high of $0.17.

PURE Bioscience (OTCMKTS:PURE) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.47 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.